Barbara Engelhardt Elected Fellow of the International Society for Computational Biology
Barbara Engelhardt, PhD, a senior investigator at Gladstone Institutes, has been elected as a fellow to the International Society for Computational Biology, joining 14 other scientists from around the world who earn the distinction this year.
The ISCB Fellows program is a prestigious recognition within the field of computational biology honoring those who have made outstanding contributions to the discipline. These distinguished scientists and professionals have demonstrated exceptional leadership, research, and service, advancing the frontiers of computational biology and bioinformatics, the society said in a statement: “Induction as an ISCB Fellow signifies a career of significant impact and a commitment to advancing the field.”
Engelhardt, who’s also a professor in the Department of Biomedical Data Science at Stanford University, is globally acclaimed for advancing statistical and machine learning models that analyze a large number of variables in biomedical research. Her work spans genomic data, imaging data, and the vast troves of electronic medical record data that could be used to predict the best course of treatment or correct health inequities.
“The medical universe today generates an overwhelming amount of information, from the DNA of individual patients to the health care system as a whole,” Engelhardt says. “With the right tools and approaches, we can mine these mountains of data for actionable trends and information that will lead to better health.”
Like many members of the Gladstone Institute of Data Science & Biotechnology, Engelhardt’s work influences a broad spectrum of health and disease. For example, her analysis of health care data has led to a policy for weaning patients from a mechanical ventilator; in a different study, she analyzed how traumatic events are stored in cells, sometimes leading to disease. Most recently, in a study that appeared in Nature Methods, she developed a computational method for gaining an in-depth picture of a tumor from a small tissue sample.
“With the right tools and approaches, we can mine these mountains of data for actionable trends and information that will lead to better health.”
Engelhardt opened her Gladstone laboratory in 2021. She previously served as a full professor at Princeton University and assistant professor at Duke University, where she started her first lab. She was a postdoctoral researcher at the University of Chicago after completing her PhD in computer science at UC Berkeley. Recognized with the 2020 Overton Prize, also from ISCB, her emphasis on interpretable, robust, and computationally efficient methods has led to crucial discoveries in genetics, genomics, and epidemiology.
“Barbara is not only a rare scientific talent who’s making a tremendous impact on health and medicine, but she is also an impeccable leader and mentor who promotes diversity and inclusion in her laboratory and throughout Gladstone,” says Gladstone Senior Investigator Katie Pollard, PhD, director of the Gladstone Institute for Data Science and Biotechnology. “We congratulate Barbara on this major career achievement and look forward to all of the discoveries still to come from her work.”
ISCB will be honoring the 2024 Class of Fellows during its annual conference in July.
Up Next
Christina Theodoris Honored in Inaugural Cohort of Young American Scientists
Scientific American recognizes Theodoris for her pioneering work developing artificial intelligence models to find treatments for an array of diseases.
How an AI Microscope Is Learning to Do Science
Gladstone scientists have developed a thinking microscope that can conduct its own experiments, with the ultimate goal of treating neurodegenerative diseases.
Gladstone Launches Center for PhAIge Therapy to Harness AI in the Fight Against Drug-Resistant Infections
The center, funded by an NIH grant, will become one of three national centers dedicated to accelerating the development of phage therapy.
AI Discovery Reveals DNA Isn’t Locked Away in Cells After All
A new study upends long-held view about how DNA is stored, explaining how subtle shifts in gene activity contribute to cancer, aging, and other complex diseases.
Get Involved
Join the Team
Our people are our most important asset. We offer a wide array of career opportunities both in our administrative offices and in our labs.
Open PositionsPartner With Us
Discoveries don’t stay in our labs. Gladstone facilitates spinout companies to advance promising therapies, shortening the path between scientific discovery and helping real patients.
Learn MoreGive
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Donate Now